“…Supportive measures aimed at improving selenoprotein biosynthesis in COVID-19 may enable a better redox control and fine-tuned response of the immune system [41]. It appears meaningful, timely, and promising to initiate population-wide measures trying to identify subjects with pre-existing Se deficits, not just as a preventive measure for viral infections, spread, and virulence development [11,12,42], but also to reduce the individual risk for cardiovascular mortality [44][45][46][47], cancer [21,48,49], and death from severe disease [10,14,39]. infections, spread, and virulence development [11,12,42], but also to reduce the individual risk for cardiovascular mortality [44][45][46][47], cancer [21,48,49], and death from severe disease [10,14,39].…”